Effect of LUX and IB on anti-IgM-induced phosphorylation of LYN in JeKo-1 and RL cells. by Himangshu Sonowal (14761882)

Effect of LUX and IB on anti-IgM-induced activation of BLNK and BLNK-BTK interactions in SU-DHL-6 cells. by Himangshu Sonowal (14761882)

miR-146b-5p expression is decreased in monocytes of obese subjects and is regulated by globular adiponectin. by Maarten Hulsmans (181118)

In vivo targeting of miR-155-5p with an antagomir effectively decreases expression but has no impact on disease. by Maximilian W. Plank (839968)

Spatial stability is decreased in APP/PS1 mice in both dCA1 and vCA1. by Udaysankar Chockanathan (18510288)

“…<p>(A) In dCA1, stability score was significantly decreased in APP/PS1 mice relative to C57BL/6 mice (mean ± std: C57BL/6 = -0.009 ± 0.292, APP/PS1 = -0.1845 ± 0.256, p < 10⁻⁶, two-sided Wilcoxon rank-sum test, n_C57BL/6 = 295 units from 5 recording sessions, n_APP/PS1 = 167 units from 4 recording sessions). …”

Blockade of GITR/GITRLigand pathway decreased BDC2.5 T cell migration and proliferation in the pancreatic lymph nodes. by Sylvaine You (369055)

Image_5_C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.JPEG by Quan-you Zheng (713217)

“…Moreover, C5aR1 deficiency significantly decreased IMQ-induced infiltration of plasmacytoid dendritic cells (pDCs), monocytes and neutrophils in psoriatic skin lesions and functions of pDCs, evidenced by the remarkable reduction in the IMQ-induced production of interferon-α (IFN-α) and tumor necrosis factor α (TNF-α), and FMS-like tyrosine kinase 3 ligand (FLT3L)-dependent pDCs differentiation. …”

TITAN decreaser macroinvertebrate heatmap Heatmap of sensitive (i.e., <i>z-</i>) macroinvertebrate taxa (y-axis) to at least one of the five stressors, in decreasing order of numbe... by Brent J. Bellinger (21156150)

Pairwise correlations in APP/PS1 mice are decreased in dCA1, but increased in vCA1. by Udaysankar Chockanathan (18510288)

Diabetic wounds show increased amounts of vessel leakage and decreased pericyte coverage. by Uzoagu A. Okonkwo (8754933)

Spatial information is significantly decreased in dCA1 and vCA1 in APP/PS1 mice. by Udaysankar Chockanathan (18510288)

“…(B) In dCA1, spatial information was decreased in APP/PS1 mice relative to C57BL/6 controls (mean ± std: C57BL/6 = 0.132 ± 0.048, APP/PS1 = 0.128 ± 0.051, p < 0.005, two-sided Wilcoxon rank-sum test, n_C57BL/6 = 305 units from 5 recording sessions, n_APP/PS1 = 180 units from 4 recording sessions). …”

Quercetin decreases proliferation (A) and induces apoptosis (B) in cultured PASMC from control rats. by Daniel Morales-Cano (668199)

Fluorescence of 5-Arylvinyl-5′-Methyl-2,2′-Bipyridyl Ligands and Their Zinc Complexes by Ali H. Younes (1589731)

“…The photophysical properties of 5-arylvinyl-5′-methyl-2,2′-bipyridyls (AVMBs, <b>1</b>−<b>9</b>, <b>11</b>) and their zinc complexes were studied. …”

Model selection for the move persistence mixed effects model fitted to 22 naïve grey seal pup tracks interpolated at a six-hour time step and estimate move persistence (γ<sub>t</su... by Benia V. R. Nowak (17054285)

Procedure related data, LBNP, LBPP and hypoxia. by Marcus Thudium (6441863)

“…Decreasing levels of LBNP were applied in 5-minute steps until subjects reached presyncope. …”

Individual biometric data of patients. by Marcus Thudium (6441863)

“…Decreasing levels of LBNP were applied in 5-minute steps until subjects reached presyncope. …”

ADAP deficiency decreases VLA-1 expression in CD8+ T cells with increased amount of H5N1 virus. by Chunyang Li (611137)

Ni causes a decrease in membrane sterols in A549 lung epithelial cells. by Amber R. Matha (19681603)

Genetic interaction of OPRM1 and 5-HT1a. by Jeanette Tour (10790855)

Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

“…<p><b>a.</b> SCID mice (n = 5/group) bearing VCaP tumour xenografts were injected intravenously either with NaCl 0.9%, non-vectorized siRNA TMPRSS2-ERG IV, NPs siRNA control-SQ or NPs siRNA TMPRSS2-ERG IV-SQ twice per week during 6 weeks (1.8 mg/kg/mouse cumulative dose). …”